Justin B Echouffo-Tcheugui1, Rebecca K Simmons1, A Toby Prevost2, Kate M Williams3, Ann-Louise Kinmonth3, Nicholas J Wareham1, Simon J Griffin4. 1. MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom. 2. Department of Primary Care and Public Health Sciences, School of Medicine, King's College London, London, United Kingdom. 3. The Primary Care Unit, Cambridge Institute of Public Health, Cambridge, United Kingdom. 4. MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom The Primary Care Unit, Cambridge Institute of Public Health, Cambridge, United Kingdom sjg49@medschl.cam.ac.uk.
Abstract
PURPOSE: There is limited trial evidence concerning the long-term effects of screening for type 2 diabetes on population morbidity. We examined the effect of a population-based diabetes screening program on cardiovascular morbidity, self-rated health, and health-related behaviors. METHODS: We conducted a pragmatic, parallel-group, cluster-randomized controlled trial of diabetes screening (the ADDITION-Cambridge study) including 18,875 individuals aged 40 to 69 years at high risk of diabetes in 32 general practices in eastern England (27 practices randomly allocated to screening, 5 to no-screening for control). Of those eligible for screening, 466 (2.9%) were diagnosed with diabetes. Seven years after randomization, a random sample of patients was sent a postal questionnaire: 15% from the screening group (including diabetes screening visit attenders and non-attenders) and 40% from the no-screening control group. Self-reported cardiovascular morbidity, self-rated health (using the SF-8 Health Survey and EQ-5D instrument), and health behaviors were compared between trial groups using an intention-to-screen analysis. RESULTS: Of the 3,286 questionnaires mailed out, 1,995 (61%) were returned, with 1,945 included in the analysis (screening: 1,373; control: 572). At 7 years, there were no significant differences between the screening and control groups in the proportion of participants reporting heart attack or stroke (OR = 0.90, 95% CI, 0.71-1.15); SF-8 physical health summary score as an indicator of self-rated health status (β -0.33, 95% CI, -1.80 to 1.14); EQ-5D visual analogue score (β: 0.80, 95% CI, -1.28 to 2.87); total physical activity (β 0.50, 95% CI, -4.08 to 5.07); current smoking (OR 0.97, 95% CI, 0.72 to 1.32); and alcohol consumption (β 0.14, 95% CI, -1.07 to 1.35). CONCLUSIONS: Invitation to screening for type 2 diabetes appears to have limited impact on population levels of cardiovascular morbidity, self-rated health status, and health behavior after 7 years.
RCT Entities:
PURPOSE: There is limited trial evidence concerning the long-term effects of screening for type 2 diabetes on population morbidity. We examined the effect of a population-based diabetes screening program on cardiovascular morbidity, self-rated health, and health-related behaviors. METHODS: We conducted a pragmatic, parallel-group, cluster-randomized controlled trial of diabetes screening (the ADDITION-Cambridge study) including 18,875 individuals aged 40 to 69 years at high risk of diabetes in 32 general practices in eastern England (27 practices randomly allocated to screening, 5 to no-screening for control). Of those eligible for screening, 466 (2.9%) were diagnosed with diabetes. Seven years after randomization, a random sample of patients was sent a postal questionnaire: 15% from the screening group (including diabetes screening visit attenders and non-attenders) and 40% from the no-screening control group. Self-reported cardiovascular morbidity, self-rated health (using the SF-8 Health Survey and EQ-5D instrument), and health behaviors were compared between trial groups using an intention-to-screen analysis. RESULTS: Of the 3,286 questionnaires mailed out, 1,995 (61%) were returned, with 1,945 included in the analysis (screening: 1,373; control: 572). At 7 years, there were no significant differences between the screening and control groups in the proportion of participants reporting heart attack or stroke (OR = 0.90, 95% CI, 0.71-1.15); SF-8 physical health summary score as an indicator of self-rated health status (β -0.33, 95% CI, -1.80 to 1.14); EQ-5D visual analogue score (β: 0.80, 95% CI, -1.28 to 2.87); total physical activity (β 0.50, 95% CI, -4.08 to 5.07); current smoking (OR 0.97, 95% CI, 0.72 to 1.32); and alcohol consumption (β 0.14, 95% CI, -1.07 to 1.35). CONCLUSIONS: Invitation to screening for type 2 diabetes appears to have limited impact on population levels of cardiovascular morbidity, self-rated health status, and health behavior after 7 years.
Authors: S A Bingham; C Gill; A Welch; A Cassidy; S A Runswick; S Oakes; R Lubin; D I Thurnham; T J Key; L Roe; K T Khaw; N E Day Journal: Int J Epidemiol Date: 1997 Impact factor: 7.196
Authors: N Waugh; G Scotland; P McNamee; M Gillett; A Brennan; E Goyder; R Williams; A John Journal: Health Technol Assess Date: 2007-05 Impact factor: 4.014
Authors: Tim Doran; Catherine Fullwood; Hugh Gravelle; David Reeves; Evangelos Kontopantelis; Urara Hiroeh; Martin Roland Journal: N Engl J Med Date: 2006-07-27 Impact factor: 91.245
Authors: Rebecca K Simmons; Justin B Echouffo-Tcheugui; Stephen J Sharp; Lincoln A Sargeant; Kate M Williams; A Toby Prevost; Ann Louise Kinmonth; Nicholas J Wareham; Simon J Griffin Journal: Lancet Date: 2012-10-04 Impact factor: 79.321
Authors: Weinan Dong; Will Ho Gi Cheng; Emily Tsui Yee Tse; Yuqi Mi; Carlos King Ho Wong; Eric Ho Man Tang; Esther Yee Tak Yu; Weng Yee Chin; Laura Elizabeth Bedford; Welchie Wai Kit Ko; David Vai Kiong Chao; Kathryn Choon Beng Tan; Cindy Lo Kuen Lam Journal: BMJ Open Date: 2022-05-24 Impact factor: 3.006
Authors: Jeanine B Albu; Nancy Sohler; Rui Li; Xuan Li; Edwin Young; Edward W Gregg; Dennis Ross-Degnan Journal: Diabetes Care Date: 2017-06-15 Impact factor: 19.112
Authors: Weinan Dong; Tsui Yee Emily Tse; Lynn Ivy Mak; Carlos King Ho Wong; Yuk Fai Eric Wan; Ho Man Eric Tang; Weng Yee Chin; Laura Elizabeth Bedford; Yee Tak Esther Yu; Wai Kit Welchie Ko; Vai Kiong David Chao; Choon Beng Kathryn Tan; Lo Kuen Cindy Lam Journal: J Diabetes Investig Date: 2022-03-28 Impact factor: 3.681
Authors: Nadia Minian; Tricia Corrin; Mathangee Lingam; Wayne K deRuiter; Terri Rodak; Valerie H Taylor; Heather Manson; Rosa Dragonetti; Laurie Zawertailo; Osnat C Melamed; Margaret Hahn; Peter Selby Journal: BMC Public Health Date: 2020-06-12 Impact factor: 3.295